The Safety and Immunogenicity of GTU(®)MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART

Previous studies have shown targeting different tissues via the transcutaneous (TC) and intramuscular injection (IM) with or without electroporation (EP) has the potential to trigger immune responses to DNA vaccination. The CUTHIVTHER 001 Phase I/II randomized controlled clinical trial was designed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Haidari, G., Day, Suzanne, Wood, M., Ridgers, H., Cope, Alethea V., Fleck, Sue, Yan, Celine, Reijonen, Kalevi, Hannaman, Drew, Spentzou, Aggeliki, Hayes, Peter, Vogt, A., Combadiere, Behazine, Cook, Adrian, McCormack, Sheena, Shattock, Robin J.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6923267/
https://ncbi.nlm.nih.gov/pubmed/31921170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02911
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars